BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24795288)

  • 1. Timing of income assistance payment and overdose patterns at a Canadian supervised injection facility.
    Zlotorzynska M; Milloy MJ; Richardson L; Nguyen P; Montaner JS; Wood E; Kerr T
    Int J Drug Policy; 2014 Jul; 25(4):736-9. PubMed ID: 24795288
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 6. Safe injection facilities save lives.
    Beyrer C
    Lancet; 2011 Apr; 377(9775):1385-6. PubMed ID: 21497899
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
    Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
    Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised injection services: what has been demonstrated? A systematic literature review.
    Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
    Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lessons learned from the fentanyl overdose crises in British Columbia, Canada.
    Thomson E; Lampkin H; Maynard R; Karamouzian M; Jozaghi E
    Addiction; 2017 Nov; 112(11):2068-2070. PubMed ID: 28901045
    [No Abstract]   [Full Text] [Related]  

  • 11. [The initial experience in supervised injecting facilities in Denmark].
    Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
    Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in needle exchange use in Vancouver, Canada coincides with the Australian heroin shortage.
    Small W; Wood E; Buchner C; Fair B; Kerr T
    Int J Drug Policy; 2008 Aug; 19(4):291-2; discussion 295-6. PubMed ID: 18424114
    [No Abstract]   [Full Text] [Related]  

  • 13. Ireland is to install supervised injecting rooms.
    Houston M
    BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
    [No Abstract]   [Full Text] [Related]  

  • 14. Vancouver's supervised injection facility challenges Canada's drug laws.
    Dooling K; Rachlis M
    CMAJ; 2010 Sep; 182(13):1440-4. PubMed ID: 20805208
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation.
    Sergeev B; Karpets A; Sarang A; Tikhonov M
    J Urban Health; 2003 Jun; 80(2):212-9. PubMed ID: 12791797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
    Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
    Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction and needle exchange programmes.
    Bluthenthal RN; Kral AH; Lorvick J; Erringer EA; Edlin BR
    Lancet; 1998 Jun; 351(9118):1819-20. PubMed ID: 9635989
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
    Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
    J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.